Michael S. Ostrach
2014 - Dynavax Technologies
In 2014, Michael S. Ostrach earned a total compensation of $1.2M as Senior Vice President, Chief Financial Officer, Chief Business Officer at Dynavax Technologies, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $221,345 |
|---|---|
| Option Awards | $425,331 |
| Salary | $354,152 |
| Stock Awards | $181,000 |
| Total | $1,181,828 |
Ostrach received $425.3K in option awards, accounting for 36% of the total pay in 2014.
Ostrach also received $221.3K in non-equity incentive plan, $354.2K in salary and $181K in stock awards.
Rankings
In 2014, Michael S. Ostrach's compensation ranked 6,846th out of 13,032 executives tracked by ExecPay. In other words, Ostrach earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,846 out of 13,032 | 48th |
Division Manufacturing | 2,509 out of 4,966 | 50th |
Major group Chemicals And Allied Products | 850 out of 1,686 | 50th |
Industry group Drugs | 670 out of 1,365 | 51st |
Industry Pharmaceutical Preparations | 512 out of 1,043 | 51st |
Source: SEC filing on April 21, 2017.
Ostrach's colleagues
We found four more compensation records of executives who worked with Michael S. Ostrach at Dynavax Technologies in 2014.